» Articles » PMID: 29338075

Liver Kinase B1/AMP-activated Protein Kinase-mediated Regulation by Gentiopicroside Ameliorates P2X7 Receptor-dependent Alcoholic Hepatosteatosis

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2018 Jan 17
PMID 29338075
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Regulating P2X7 receptor-mediated activation of NLRP3 inflammasomes could be a therapeutic strategy to treat alcoholic hepatosteatosis. We investigated whether this process was modulated by gentiopicroside, the main active secoiridoid glycoside from Gentiana manshurica Kitagawa.

Experimental Approach: In vivo models of acute and chronic alcoholic hepatosteatosis were established by intragastrically administered ethanol or using chronic plus binge ethanol feeding of Lieber-DeCarli liquid diet to male C57BL/6 mice. In vitro, HepG2 cells were treated with ethanol. RAW 264.7 macrophages and murine bone marrow-derived macrophages (BMDMs) were stimulated with LPS and ATP.

Key Results: In both the acute and chronic alcohol-induced mouse hepatosteatosis models, gentiopicroside decreased serum aminotransferases and triglyceride accumulation. Up-regulated SREBP1, down-regulated PPARα and phosphorylated acetyl-CoA carboxylase caused by acute and chronic alcohol feeding were modulated by gentiopicroside, through the elevation of LKB1 and AMPK. Suppression of P2X7 receptor-NLRP3 activation by gentiopicroside inhibited IL-1β production. In ethanol-exposed HepG2 cells, gentiopicroside reduced lipogenesis and promoted lipid oxidation via activation of P2X7 receptor-NLRP3 inflammasomes. Genetic or pharmacological blockade of P2X7 receptors enhanced AMPK activity and reduced SREBP1 expression in ethanol-treated HepG2 cells. Gentiopicroside down-regulated P2X7 receptor-mediated inflammatory responses in LPS/ATP-stimulated RAW 264.7 macrophages and BMDMs. IL-1β from macrophages accelerated lipid accumulation in hepatocytes. Depleting macrophages by clodronate liposomes ameliorated alcoholic hepatosteatosis, and it was further alleviated by gentiopicroside.

Conclusions And Implications: Activation of LKB1/AMPK signalling by gentiopicroside was mediated by the P2X7 receptor-NLRP3 inflammasome, suggesting the therapeutic value of blocking P2X7 receptors in the treatment of alcoholic hepatosteatosis.

Citing Articles

Gentiopicroside ameliorates psoriasis-like skin lesions in mice via regulating the Keap1-Nrf2 pathway and inhibiting keratinocyte activation.

Ren J, Chen X, Wang H, Yang T, Zhang K, Lei S Acta Pharmacol Sin. 2025; .

PMID: 39779965 DOI: 10.1038/s41401-024-01449-8.


The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma.

Xie Q, Zeng Y, Zhang X, Yu F Cancer Immunol Immunother. 2024; 73(9):171.

PMID: 38954021 PMC: 11220057. DOI: 10.1007/s00262-024-03748-9.


Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1.

Huang C, Yong Q, Lu Y, Wang L, Zheng Y, Zhao L Front Pharmacol. 2024; 15:1335814.

PMID: 38515850 PMC: 10956515. DOI: 10.3389/fphar.2024.1335814.


Combination of Formononetin and Sulforaphane Natural Drug Repress the Proliferation of Cervical Cancer Cells via Impeding PI3K/AKT/mTOR Pathway.

Jiang P, Jiang W, Li X, Zhu Q Appl Biochem Biotechnol. 2024; 196(10):6726-6744.

PMID: 38401043 DOI: 10.1007/s12010-024-04873-y.


Gentiopicroside-An Insight into Its Pharmacological Significance and Future Perspectives.

Antoniadi L, Bartnik M, Angelis A, Wawruszak A, Halabalaki M, Kukula-Koch W Cells. 2024; 13(1).

PMID: 38201274 PMC: 10778152. DOI: 10.3390/cells13010070.


References
1.
Mathurin P, OGrady J, Carithers R, Phillips M, Louvet A, Mendenhall C . Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2010; 60(2):255-60. DOI: 10.1136/gut.2010.224097. View

2.
Curtis M, Bond R, Spina D, Ahluwalia A, Alexander S, Giembycz M . Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol. 2015; 172(14):3461-71. PMC: 4507152. DOI: 10.1111/bph.12856. View

3.
Alexander S, Fabbro D, Kelly E, Marrion N, Peters J, Faccenda E . THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes. Br J Pharmacol. 2017; 174 Suppl 1:S272-S359. PMC: 5650666. DOI: 10.1111/bph.13877. View

4.
Dinarello C . Interleukin-1beta and the autoinflammatory diseases. N Engl J Med. 2009; 360(23):2467-70. DOI: 10.1056/NEJMe0811014. View

5.
Sozio M, Lu C, Zeng Y, Liangpunsakul S, Crabb D . Activated AMPK inhibits PPAR-{alpha} and PPAR-{gamma} transcriptional activity in hepatoma cells. Am J Physiol Gastrointest Liver Physiol. 2011; 301(4):G739-47. PMC: 3191559. DOI: 10.1152/ajpgi.00432.2010. View